A 30-year-old blue-fronted Amazon parrot (Amazon aestiva aestiva) was presented to the clinic with a history of sneezing more often during the last 2 mo. Physical examination revealed only a mild nasal discharge. Complete hematological and plasma biochemical examination showed no abnormalities. Computerized Tomography (CT) of the complete bird was performed showing generalized lung alterations consistent with lung fibrosis. Two lung biopsies were taken. The results of the histological examination showed chronic pulmonary interstitial fibrosis (CPIF), a syndrome characterized by a chronic respiratory disease resulting in exercise intolerance. The etiology of this syndrome was not identified but it was suggested that toxic substances, bacterial and chemical toxins, allergy (5) or viral infections could play a role in the pathogenesis of CPIF in birds. Interstitial lung diseases (ILDs) in veterinary medicine are poorly characterized. This is the first reported case of chronic pulmonary interstitial fibrosis diagnosed by means of a lung biopsy in an avian species.
The purpose of this article is to describe a case of chronic pulmonary interstitial fibrosis diagnosed in a Blue-fronted Amazon parrot and to compare it with the actual knowledge of interstitial lung diseases in humans.
Chronic pulmonary interstitial fibrosis (CPIF) was described for the first time in birds in a retrospective study conducted at the Department of Pathobiology, section Diseases of Special Animals and Wildlife (Faculty of Veterinary Medicine, Universiteit Utrecht) by Zandvliet et al. In their study, 25 Amazon parrots (Amazona spp.) submitted for necropsy had histological lesions of chronic pulmonary interstitial fibrosis.
In domestic animals these diseases are usually called idiopathic pulmonary fibrosis (IPF). This terminology is confusing since they do not share the same histopathological characteristics as described for IPF in humans. In animals IPF was first described in West Highland white terriers but other breeds can be affected. It has also been described in several occasions in cats. Furthermore, spontaneous feline idiopathic pulmonary fibrosis has recently been described with the same characteristics as IPF in humans.
In humans idiopathic pulmonary fibrosis (IPF) is a progressive and lethal pulmonary disease that belongs to the interstitial lung diseases (ILDs). Pulmonary fibrosis is a characteristic of more than 200 interstitial lung diseases (ILDs). ILDs are a group of lung diseases characterized by chronic inflammation and progressive fibrosis of the pulmonary interstitium. ILDs can be classified in the following categories: Lung biopsies are one of the best methods for the diagnosis of IPF but it is not always definitive. The histological features of IPF are called Usual Interstitial Pneumonia (UIP) and are as follows: temporary heterogeneity of lung remodeling, with the primary changes involved being interstitial fibrosis and ongoing fibroblast/myofibroblast proliferation, ''honeycomb'' change (enlarged airspaces lined by prominent variable epithelium) and, in some cases, inflammation. The distribution of the lesions is typically patchy, with normal areas of lung interspersed with adjacent foci of fibrosis and honeycomb change. This distribution is also important in the IPF diagnosis.
In this case, the CT images suggested the presence of a diffuse lung disease with dilation and increase in diameter of bronchiolar walls (Fig. 1 ). There were also areas of increased density in the caudoventral lung. These findings were compatible with the macroscopic characteristics found on postmortem examination of Amazon parrots in the study by Zandvliet et al. but not with the CT images of human IPF. The histology results of the lung biopsies taken in this patient showed lung tissue that no longer contained air with local loss of respiratory component, fibrosis and diffuse increase of interstitial connective tissue suggestive of chronic pulmonary interstitial fibrosis. The histological lesions are compatible with the fibrotic lesions observed in human IPPs but they differ from the histological changes found in IPF. No evidence of inflammation or etiologic agent could be seen although it cannot be excluded due to the reduced number of biopsies taken. The differences in anatomy and physiology between avian and mammal (human) lungs makes the CT imaging characteristics and the histopathological identification of this lung disease difficult.
In conclusion, this is the first report of a psittacine species diagnosed ante-mortem with CIPF. The etiology of this syndrome was not found. More research is needed in order to describe this histopathological condition of chronic interstitial pulmonary fibrosis in birds and its possible etiology and treatment. 
